Editorial Comment to OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis)

Saved in:
Bibliographic Details
Published inInternational journal of urology Vol. 27; no. 3; pp. 234 - 235
Main Author Takeda, Masayuki
Format Journal Article
LanguageEnglish
Published Australia Wiley Subscription Services, Inc 01.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
Author Takeda, Masayuki
Author_xml – sequence: 1
  givenname: Masayuki
  surname: Takeda
  fullname: Takeda, Masayuki
  email: matakeda@yamanashi.ac.jp
  organization: University of Yamanashi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32166840$$D View this record in MEDLINE/PubMed
BookMark eNp9ks9uEzEQxhdURNPCgRsnNBKXRGpae73ZzXKLogKpKlVC9Lzyn1niymsvtrclnHgEnpEnwUlKhSqBLyN_-s039swcZQfWWcyyV5Sc0nTO9M1wSos8L59mI1oU-TQnRX6QjUhN6-mcVvlhdhTCDSGU5XT-PDtMoSznBRk9eX2udHRecwNL13VoI0QHV5YLFwej7dBF903bBYwfBNgpEDc9wmICrfMQ1wjRI487A9fCBe-5xYDQ86iTFuBOxzW4W_RcRn2LIAxXCj1wq2Dw2nK_AW2ls1FbtBLfwScMg0mZyS5o-8Xgrx8_lQt_V2q964BDv-ZJXq1WJ-CTn-v0d1QnoNwgdlkivTvde8MlCpeEbRnvjEGVzLZ_H2sb0etkZrnZBB0mL7JnLTcBX97H4-z6_fnn5cfp5dWH1XJxOZWsqsopVnyWzxSpSNVyNqulElQVVHFOiSxYLtUMy6IUghUtIpW1UIozRnIuZnVLS3acjfe-vXdfBwyx6XSQaEzqnxtCk6cyjNWEkYS-fYTeuMGnB--osqgpZSxRb-6pQXSomj59KzW3-TPzBEz2gPQuBI_tA0JJs92nJu1Ts9unxJ49YqWOaaTb_nFt_pdxpw1u_m3drC6u9xm_AXuS5Po
CitedBy_id crossref_primary_10_3143_geriatrics_59_115
Cites_doi 10.1111/j.1442-2042.2012.03218.x
10.1016/j.juro.2012.12.022
10.1111/iju.14176
10.1016/j.eururo.2013.04.001
ContentType Journal Article
Copyright 2020 The Japanese Urological Association
Copyright © 2020 The Japanese Urological Association
Copyright_xml – notice: 2020 The Japanese Urological Association
– notice: Copyright © 2020 The Japanese Urological Association
DBID AAYXX
CITATION
NPM
7QP
K9.
7X8
DOI 10.1111/iju.14226
DatabaseName CrossRef
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1442-2042
EndPage 235
ExternalDocumentID 32166840
10_1111_iju_14226
IJU14226
Genre commentary
Journal Article
Commentary
Editorial
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29J
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAYXX
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7QP
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
ID FETCH-LOGICAL-c3776-e7a525d0707fa359cdb1d41daa10c432cd5e646bb34fee1c9bdda3302ab59f163
IEDL.DBID DR2
ISSN 0919-8172
1442-2042
IngestDate Fri Jul 11 04:19:38 EDT 2025
Sun Jul 13 04:49:22 EDT 2025
Wed Feb 19 02:31:16 EST 2025
Tue Jul 01 03:50:07 EDT 2025
Thu Apr 24 23:02:09 EDT 2025
Wed Jan 22 16:34:49 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3776-e7a525d0707fa359cdb1d41daa10c432cd5e646bb34fee1c9bdda3302ab59f163
Notes SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
PMID 32166840
PQID 2376491133
PQPubID 2045142
PageCount 2
ParticipantIDs proquest_miscellaneous_2377339030
proquest_journals_2376491133
pubmed_primary_32166840
crossref_primary_10_1111_iju_14226
crossref_citationtrail_10_1111_iju_14226
wiley_primary_10_1111_iju_14226_IJU14226
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2020
2020-03-00
2020-Mar
20200301
PublicationDateYYYYMMDD 2020-03-01
PublicationDate_xml – month: 03
  year: 2020
  text: March 2020
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Hoboken
PublicationTitle International journal of urology
PublicationTitleAlternate Int J Urol
PublicationYear 2020
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2013; 189
2020; 27
2013; 64
2013; 20
e_1_2_3_2_1
e_1_2_3_7_1
e_1_2_3_6_1
e_1_2_3_5_1
e_1_2_3_4_1
e_1_2_3_3_1
References_xml – volume: 64
  start-page: 249
  year: 2013
  end-page: 56
  article-title: OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double‐blind, placebo controlled trial
  publication-title: Eur. Urol.
– volume: 20
  start-page: 94
  year: 2013
  end-page: 9
  article-title: Botulinum toxin type A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients
  publication-title: Int. J. Urol.
– volume: 27
  start-page: 227
  year: 2020
  end-page: 34
  article-title: OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis)
  publication-title: Int. J. Urol.
– volume: 189
  start-page: 2186
  year: 2013
  end-page: 93
  article-title: OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial
  publication-title: J. Urol.
– ident: e_1_2_3_7_1
  doi: 10.1111/j.1442-2042.2012.03218.x
– ident: e_1_2_3_3_1
  doi: 10.1016/j.juro.2012.12.022
– ident: e_1_2_3_2_1
  doi: 10.1111/iju.14176
– ident: e_1_2_3_5_1
– ident: e_1_2_3_4_1
  doi: 10.1016/j.eururo.2013.04.001
– ident: e_1_2_3_6_1
SSID ssj0013218
Score 2.2272315
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 234
SubjectTerms Botulinum toxin type A
Title Editorial Comment to OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis)
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fiju.14226
https://www.ncbi.nlm.nih.gov/pubmed/32166840
https://www.proquest.com/docview/2376491133
https://www.proquest.com/docview/2377339030
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEFZDDqWXvttsk5Zp6WED8WJbsl23p6UkZBfSQuhCDgUjWTJx69hhbUPIqT-hv7G_pDPyg00fUAp78GolS7ZGM7Ojbz4x9jqOhfLw43heJhwRuZETu1o66GzwMM10lloQzcmH8HgllmfB2RZ7N-TCdPwQY8CNVobV17TApao3Fnn-pZ3ZPFDUv4TVIofo1N_YQbCxPTSHFOaK_J5ViFA8Y8ubtug3B_Omv2oNztE99nkYaocz-TprGzVLr39hcfzPZ7nP7vaOKMw7yXnAtkz5kN0-6bfaH93aOdQ5EYhgHUoiQdsETQUfSxSahtDr7UVTXeXlHKZjAdgSoKguzPcB3WFA9xJGLDtUGSzRONOhl9ATutZAkWAgIKm0qhdUQcpwDbLUQFsB-FRAFBJ0pAWpobdwauq2wJZ4O4p0FObHt--6qjd7oqwZkHB5jkYaFovFAaBN1tVFfm30AeiqVbaVwnHjdwtMUxUW9Mj9wmiw55nAlPg01jnerGdv2X_MVkeHn94fO_0xEk7Koyh0TCQDP9DEa5RJHsSpVp4WnpbSc1PB_VQHJhShUlxkxnhprLSWnLu-VEGcob_6hG2XVWl2GFBOU6CNFIFSgmfRm9iToSeFiy8GPT8xYdNBoJK051inoz6KZPivhTOd2JmesFdj1cuOWORPlfYGqUx63VInhGMSaKM4n7CX48-oFWirB6ewam2diPMYNfiEPe2keewFV0ZIFD84WCuTf-8-WSxX9uLZv1fdZXd8CklYmN4e227WrXmOflujXtgF-hNAV0cX
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwEDdjSMAL_2GFAQfioZOWqomdhCBeKrSpLeuQplXaC4rs2NEysmRqEwntiY_AZ-STcOekUccfCSH1oXXOsVOf7y7nu98x9iaKhHLx47huKhwRDkMnGmrpoLHBgyTVaWKDaGaHwXgupif-yQZ7v8qFafAhOocb7Qwrr2mDk0N6bZdnZ_XAJoJeZzeoord9oTry1s4QrHcPFSI5ukKvxRWiOJ6u61Vt9JuJedVitSpn_y77vJpsE2nyZVBXapBc_oLj-L9Pc4_daW1RGDXMc59tmOIBuzlrT9sfXtva0xlhiCAN5ZGgeoKqhE8F8k1FAez1eVV-zYoR9LsGsC1Ajl0Y7QBaxIAWJnTh7FCmMEX9THUvocV0XQI5g4FiSaWVvqBykocLkIUGOg3AxwJCkaCqFiSJ3sGRWdY59sTbkbMjNz--fdflcn0kSpwBCRenqKdhMpnsAqplXZ5nl0bvgi5rZXspnDf-trFpqsSGNng_NxpsSRPoE6TGIsObtQAuO4_YfH_v-MPYaStJOAkPw8AxofQ9XxO0USq5HyVauVq4Wkp3mAjuJdo3gQiU4iI1xk0ipbXkfOhJ5UcpmqyP2WZRFmaLAaU1-dpI4SsleBq-jVwZuFIM8Y9B40_0WH_FUXHSwqxTtY88Xr1u4UrHdqV77HVHetFgi_yJaHvFlnErXpYxhTIJVFOc99ir7jIKBjrtwSUsa0sTch6hEO-xJw07d6Pg1ggI5Qcna5ny78PHk-ncfnn676Qv2a3x8ewgPpgcfnzGbnvkobBRe9tss1rU5jmacZV6YXfrT2fISzI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwEDdjSBMv_IcVBhyIh05aqiR2kgWeKrZqLWygiUp7QIrs2BGBLqnaREJ74iPwGfkk3LlJ1PFHQkh9SN1z7MTnu-v57neMvYhjoTz8OJ6XCUdEbuTErpYOGhs8TDOdpTaI5vgkPJqKyVlwtsFetbkwK3yIzuFGO8PKa9rgc52tbfL8cz2weaBX2TURuvvE0gen_toRgnXuoT4kP1fkN7BCFMbTdb2sjH6zMC8brFbjjG6yj-1cV4EmXwZ1pQbpxS8wjv_5MLfYjcYSheGKdW6zDVPcYVvHzVn73SvbhzonBBGkoSwSVE5QlfCuQK6pKHy9Pq_Kr3kxhH7XALYFyK0Lw11AexjQvoQumB3KDCaonanqJTSIrksgVzBQJKm0shfUjKThAmShgc4C8KmAMCSopgXJoZdwapb1DHvi7cjVMTM_vn3X5XJ9JEqbAQnzT6ilYTwe7wEqZV2e5xdG74Eua2V7KZw3freRaarEhiZ0f2Y02IIm0CdAjUWON2vgW3bvseno8MPrI6epI-GkPIpCx0Qy8ANNwEaZ5EGcauVp4WkpPTcV3E91YEIRKsVFZoyXxkprybnrSxXEGRqs99lmURZmmwElNQXaSBEoJXgW7ceeDD0pXHwxaPqJHuu3DJWkDcg61fqYJe2fLVzpxK50jz3vSOcrZJE_Ee20XJk0wmWZUCCTQCXFeY89635GsUBnPbiEZW1pIs5jFOE99mDFzd0ouDNCwvjByVqe_PvwyXgytRcP_530Kdt6fzBK3o5P3jxi131yT9iQvR22WS1q8xhtuEo9sXv1J4YGSeo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Editorial+Comment+to+OnabotulinumtoxinA+%28botulinum+toxin+type+A%29+for+the+treatment+of+Japanese+patients+with+overactive+bladder+and+urinary+incontinence%3A+Results+of+single%E2%80%90dose+treatment+from+a+phase+III%2C+randomized%2C+double%E2%80%90blind%2C+placebo%E2%80%90controlled+trial+%28interim+analysis%29&rft.jtitle=International+journal+of+urology&rft.au=Takeda%2C+Masayuki&rft.date=2020-03-01&rft.issn=0919-8172&rft.eissn=1442-2042&rft.volume=27&rft.issue=3&rft.spage=234&rft.epage=235&rft_id=info:doi/10.1111%2Fiju.14226&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_iju_14226
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0919-8172&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0919-8172&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0919-8172&client=summon